Stay updated on Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page
- CheckyesterdayChange DetectedRevision updates were applied to the page, introducing new revision tags (v3.5.4) and prior version (v3.5.3) with associated dates. They reflect maintenance/version control rather than substantive changes to the trial details.SummaryDifference0.4%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe ClinicalTrials.gov page’s revision/version identifier was updated from v3.5.2 to v3.5.3, indicating a site-side software/version change with no substantive changes to the study details.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check94 days agoChange DetectedAdded Revision: v3.4.2 and removed the previous funding/operating status notice (Revision: v3.4.1).SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.